[{"uuid": "8bdbd47e-c7ad-39fb-b2f7-5098b05552d7", "title": "Institutional investors own a significant stake of 49% in Aquestive Therapeutics, Inc. (NASDAQ:AQST)", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/institutional-investors-own-significant-stake-104845877.html", "providerPublishTime": 1737974925, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "4591c05b-8d60-3f48-ab83-c66d17a4b168", "title": "Aquestive Therapeutics Provides Business Update and Outlines Key 2025 Objectives", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-provides-business-outlines-120000343.html", "providerPublishTime": 1736769600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bATSv89JEmxJZ5dbVRYEpA--~B/aD0xNzc7dz02ODk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 689, "height": 177, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WXOSVKXK66E_6wBj2qLwLg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "cb10f93d-f709-31b5-ab7a-e41a410f3bec", "title": "Aquestive Therapeutics' (NASDAQ:AQST) investors will be pleased with their favorable 88% return over the last year", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-nasdaq-aqst-investors-104218662.html", "providerPublishTime": 1734432138, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "54feddfc-5241-34b7-be7c-adf68b544952", "title": "Aquestive Therapeutics Says FDA Grants Orphan Drug Exclusivity for Libervant Buccal Film to Treat Seizure Clusters", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-says-fda-grants-153300569.html", "providerPublishTime": 1734622380, "type": "STORY", "relatedTickers": ["AQST"]}, {"uuid": "b04ac7c0-bb00-3167-9d80-8d9d806ec6fd", "title": "Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity for Libervant\u00ae (diazepam) Buccal Film in Pediatric Patients with Seizure Clusters Ages Two to Five", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-receives-u-fda-130000795.html", "providerPublishTime": 1734613200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bATSv89JEmxJZ5dbVRYEpA--~B/aD0xNzc7dz02ODk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 689, "height": 177, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WXOSVKXK66E_6wBj2qLwLg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "3f12a179-a99a-36a5-ab90-b5863767e202", "title": "Cantor Fitzgerald Initiates Aquestive Therapeutics at Overweight With $17 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cantor-fitzgerald-initiates-aquestive-therapeutics-123620000.html", "providerPublishTime": 1734438980, "type": "STORY", "relatedTickers": ["AQST"]}, {"uuid": "a973a93f-1ae1-3800-9234-601e80db65f4", "title": "Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/developer-epipen-alternative-aquestive-stock-185622679.html", "providerPublishTime": 1734461782, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/BJkv79ebr4csUDGkycSS4w--~B/aD01NzU7dz0xMDIyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/4cbeb491c5857ff74bcdd5ad97ff4160", "width": 1022, "height": 575, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/.7ypzpdpwiK9PxmyVtVzJw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/4cbeb491c5857ff74bcdd5ad97ff4160", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "09894601-d126-34cc-8e3c-949c39361dc3", "title": "Aquestive Therapeutics Gains FDA Orphan Drug Exclusivity for Pediatric Seizure Treatment", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-gains-fda-orphan-164021510.html", "providerPublishTime": 1734626421, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/slb6hco9s4qvtSd.Xyb6oQ--~B/aD0zNjQ4O3c9NTQ3MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/ac90e83fbe2c24857411d69cfbec7675", "width": 5472, "height": 3648, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/i6H5JMJ4Poi33efxhBLGXg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/ac90e83fbe2c24857411d69cfbec7675", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "3c5958f9-e2d7-3713-9d20-fff0a0588c20", "title": "Aquestive Therapeutics Receives FDA 'Positive Feedback' for Anaphylm Sublingual Film", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-receives-fda-apos-140341846.html", "providerPublishTime": 1733148221, "type": "STORY", "relatedTickers": ["AQST"]}, {"uuid": "ed2bb0b4-65a1-3fcc-a507-9802707acf0c", "title": "Is Aquestive Therapeutics (AQST) the Best Multibagger Stock to Buy Heading into 2025?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-aqst-best-multibagger-062517912.html", "providerPublishTime": 1731738317, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/4KT2192jKN.BsbQvauf_bA--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/d946cb0efcd46e6f05a8231692014039", "width": 768, "height": 430, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3TD8TkFZBBe6v2_rQt1xyg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/d946cb0efcd46e6f05a8231692014039", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}, {"uuid": "452f0e16-4918-30d6-96b8-19d4fabe1eca", "title": "Sector Update: Health Care Stocks Lower Thursday Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-lower-184940478.html", "providerPublishTime": 1734634180, "type": "STORY", "relatedTickers": ["LLY", "OMER", "AQST"]}, {"uuid": "caaa00c0-9c81-3a36-b807-6bd57b54e274", "title": "Aquestive Therapeutics Announces Positive FDA Feedback and Reaffirms NDA Submission Guidance for Anaphylm\u2122 (epinephrine) Sublingual Film", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/aquestive-therapeutics-announces-positive-fda-130000858.html", "providerPublishTime": 1733144400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/bATSv89JEmxJZ5dbVRYEpA--~B/aD0xNzc7dz02ODk7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 689, "height": 177, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/WXOSVKXK66E_6wBj2qLwLg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/38848d827b0260ef9344c723ce1f4c5a", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AQST"]}]